Adaptive Biotechnologies Corporation
ADPT
|
$2.33
-4.51%
-4.72%
2.8M
|
Commercial Services
(0.0% 1d) (-19.2% 1m) (-67.2% 1y) (0.0% 2d) (0.0% 3d) (-6.2% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-14
Market Cap: $ 338,064,991
http://www.adaptivebiotech.com
Sec Filling | Patents | 453 employees
(US) Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.
vaccine diagnostics treatment
add to watch list Paper trade email alert is off
Press-releases
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
Published: 2024-04-17 (Crawled : 20:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
| Email alert
Add to watchlist
first report biotechnologies financial results
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -0.67%
H: 0.91%
C: -9.46%
first biotechnologies review revenue update
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: 2.43%
H: 0.0%
C: -2.03%
conference biotechnologies business update
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -0.26%
H: 5.33%
C: 4.39%
conference biotechnologies
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-14 (Crawled : 21:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -8.63%
H: 17.78%
C: 10.0%
biotechnologies year financial results
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
Published: 2024-01-29 (Crawled : 21:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -0.97%
H: 0.49%
C: -3.42%
report biotechnologies year financial results
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-27 (Crawled : 21:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -0.2%
H: 7.65%
C: 4.51%
conference biotechnologies
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
Published: 2023-12-09 (Crawled : 16:20) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
| Email alert
Add to watchlist
clonoseq biotechnologies blood meeting
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
Published: 2023-12-05 (Crawled : 12:30) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -0.42%
H: 0.95%
C: -6.75%
clonoseq drug biotechnologies cancer blood care meeting
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -10.72%
H: 0.26%
C: -8.36%
biotechnologies business update financial results
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10